781
Total Claims
$50K
Drug Cost
141
Beneficiaries
$353
Cost/Patient
Peer Comparison vs. 8,961 Nephrology providers
-72%
Cost per patient vs peers
$353 vs $1,283 avg
-20%
Brand preference vs peers
7.2% vs 9.0% avg
Brand vs Generic
93% generic
Brand: 56 claims · $33K
Generic: 725 claims · $17K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Azilsartan Medoxomil | 11 | $4,755 |
| Sevelamer Carbonate | 17 | $2,060 |
| Sodium Polystyrene Sulfonate | 14 | $1,954 |
| Nifedipine | 20 | $1,532 |
| Calcium Acetate | 22 | $1,430 |
| Hydralazine Hcl | 57 | $1,196 |
| Chlorthalidone | 43 | $1,005 |
| Losartan Potassium | 59 | $819 |
| Midodrine Hcl | 14 | $642 |
| Lisinopril | 62 | $500 |
| Allopurinol | 49 | $479 |
| Valsartan | 12 | $250 |
| Metoprolol Tartrate | 34 | $221 |
| Bumetanide | 12 | $200 |
| Calcitriol | 33 | $194 |
Prescribing Profile
23
Unique Drugs
Patient Profile
75
Avg Age
50%
Female
3.10
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About